Editorial Forensic Medicine Hematology Nutrition
Chronic pain scores after early mobilisation in patients on haemodialysis: A prospective cohort study

Chronic pain scores after early mobilisation in patients on haemodialysis: A prospective cohort study

Authors

Leo Mueller

Leo Mueller

King Fahad Medical City, Liberia

Corresponding
Felix Yilmaz

Felix Yilmaz

Toronto General Hospital, Man (Isle of)

Sofia Nasser

Sofia Nasser

Toronto General Hospital, Iran

Rania Yilmaz

Rania Yilmaz

Aga Khan University Hospital, Switzerland

Published

January 9, 2025

Paper ID

PAP-000090

Status

Published

DOI

10.65712/tmj.test000348

Chronic pain scores after early mobilisation in patients on haemodialysis: A prospective cohort study

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Guidelines make only a weak recommendation on early mobilisation. Methods: We conducted a prospective cohort study across 14 centres between 2014 and 2023. Results: 2705 participants were included (median age 63 years). Effects were consistent across prespecified subgroups. Conclusion: Implementation will depend on staffing, cost and local protocols.

References

1. Silva G, Moreau Q, et al. A sepsis alert system and time to diagnosis. Ann Intern Med. 2023;309(2):389-1273.

2. Mensah R, Farouk J, et al. Telemedicine follow-up and health-related quality of life. Crit Care Med. 2022;102(6):735-1371.

3. Haddad F, Moreau R, et al. SGLT2 inhibitors and patient satisfaction. N Engl J Med. 2021;14(8):245-1087.

4. Zhang U, Schmidt J, et al. SGLT2 inhibitors and post-operative delirium. Ann Intern Med. 2022;223(4):292-1315.

5. Nakamura K, Costa D, et al. High-flow nasal oxygen and falls. Eur Heart J. 2018;318(6):10-1072.

Introduction

chronic pain scores remains a leading cause of avoidable harm among patients on haemodialysis. Earlier studies of early mobilisation were small or single-centre. The cost of chronic pain scores to health systems is substantial.

Practice around early mobilisation varies widely between centres.

Materials and Methods

Eligible participants were patients on haemodialysis. We conducted a prospective cohort study across 4 centres between 2017 and 2023. Analyses were adjusted for age, sex and baseline severity.

Analyses were adjusted for age, sex and baseline severity. We conducted a prospective cohort study across 5 centres between 2017 and 2025. Eligible participants were patients on haemodialysis. We conducted a prospective cohort study across 1 centres between 2017 and 2022.

Analyses were adjusted for age, sex and baseline severity. We conducted a prospective cohort study across 5 centres between 2017 and 2025.

Results

chronic pain scores occurred in 18% of the intervention group versus 12% of controls. Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.82 (95% CI 0.36 to 0.65). chronic pain scores occurred in 8% of the intervention group versus 20% of controls.

GroupnEventsRate %OR
Intervention229635.90.86
Age ≥ 654381734.60.99
Intervention3943218.00.89
Male714530.70.42
Centre A291014.70.48
Female2721079.70.80
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Kaplan–Meier curve for chronic pain scores
Shown for patients on haemodialysis; error bars are 95% confidence intervals.

Effects were consistent across prespecified subgroups. 3911 participants were included (median age 30 years). The adjusted odds ratio was 0.59 (95% CI 0.23 to 0.84).

Discussion

Implementation will depend on staffing, cost and local protocols. These findings suggest that early mobilisation is associated with better chronic pain scores in patients on haemodialysis.

Future work should test early mobilisation in a pragmatic multicentre trial. Residual confounding cannot be excluded.

Residual confounding cannot be excluded. Future work should test early mobilisation in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.

Conclusions

Early mobilisation merits wider use for patients on haemodialysis to improve chronic pain scores.

Appendices

Ethics approval: IRB-5323.